Valuation
- Market cap
- 117,114,000
- Revenue TTM
- $196,120,000
- Net income TTM
- $79,040,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 40.30%
- Debt to equity
- 0.00
Trading
- Volume
- 200
- Avg volume
- 7,822
- Day's range
- $0.97 – $0.97
- Shares out
- 121,551,000
- Stochastic %K
- 40%
- Beta
- -0.77
- Analysts
- —
- Price target
- —
Company profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Globa...
Show more
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 852 3605 8180
- Address
- Bank of China Tower, 48th Floor 1 Garden Road, Central, Hong Kong
Latest news
No headlines yet.
